Long-term anticoagulation of outpatients with adverse events to oral anticoagulants using low-molecular-weight heparin

Seminars in Thrombosis and Hemostasis

Volumn 23, Issue 2, 1997, Pages 167-172

  Harenberg, Job ^a   Huhle, Günter ^a   Piazolo, Lukas ^a   Giese, Christina ^a   Heene, Dieter L ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Bleeding complications; Heart valve replacement; Low molecular weight heparin; Oral anticoagulants; Thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; CERTOPARIN; DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MONOEMBOLEX; NADROPARIN;

ARTICLE; BLEEDING; CLINICAL TRIAL; FEMALE; HEART VALVE REPLACEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOSIS;

EID: 0030994151     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996086     Document Type: Article

References (29)

1. Leizorovicz A, MC Haugh, FR Chapuis. MM Samama, JP Boissel: Low molecular weight heparin in prevention of perioperative thrombosis. Br Med J 305:913-920, 1992.
2. Nurmohamed MT, FR Rosendaal, HR Büller, E Dekker, DW Hommes, JP Vanderbroucke, L Briet: Low molecular weight heparin versus standard heparin in general and orthopaedic surgery: A meta-analysis. Lancet 340:152-156, 1992.
3. Harenberg J, P Roebruck, DL Heene on behalf of the Heparin Study in Internal Medicine Group: Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. Haemostasis 26:127-139. 1996.
4. Bergmann JF, E Neuhart: A multicentric randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolism disease in elderly in-patients bedridden for an acute medical illness. Thromb Haemostas 76:529-534, 1996.
5. Harenberg J, B Kallenbach, U Martin, CE Dempfle, R Zimmermann, W Kübler, DL Heene: Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients. Thromb Res 59:639-650, 1990.
6. Keller F, CW Flosbach, and the PRIME study group: A randomized multicenter study investigating the efficacy and safety of the low molecular weight heparin enoxaparin versus unfractionated heparin in the prevention of thromboembolism in immobilized medical patients. Thromb Haemostas 73:1106 (Abstr), 1995.
7. Koopman MMW, P Prandoni, F Piovella, PA Oxford, DP Brandjes, J Van der Meer, AS Gallus, G Simonneau, CH Chesterman, MH Prins, PMM Bossuyt, H de Haas, AGM van den Belt, L Sagnard, P D'Azemar, HR Büller: Treatment of patients with proximal-vein thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low-molecular-weight heparin out of hospital or with early discharge. N Engl J Med 334: 682-687, 1996.
8. Levine M, M Gent, J Hirsh, J Leclerc, D Anderson, J Weitz, JS Ginsberg, AG Turpie, C Demers, M Kovacs, W Geerts, J Kassis, L Desjardins, J Cusson, M Cruickeshank, P Powers, W Brien, S Hary, A Willan: A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 334:677-681, 1996.
9. Harenberg J, U Schmitz-Huebner, KH Breddin, S Haas, F Heinrich, C Heinrichs, J Kienast, P Roebruck, W Theiss, E Wenzel: Treatment of deep vein thrombosis with low-molecular-weight heparins - A consensus statement of the German Society on Thrombosis and Haemostasis. Semin Thromb Hemostas 23:91-96, 1997.
10. Hirsh J: Drug therapy: Oral anticoagulant drugs. N Engl J Med 324:1865-1875, 1991.
11. Palareti G, S Leali, M Poggi, C Manotti, A D' Angelo, V Pengo, N Erba, M Moia, N Ciavarella, G Devoto, M Berrettini, S Musolesi, on behalf of the Italian Study on Complications of Oral Anticoagulant Therapy: Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Lancet 348:423-428, 1996.
12. Landefeld CS, RJ Beyth: Anticoagulant-related bleeding - Clinical epidemiology, prediction, and prevention. Am J Med 95:315-328, 1993.
13. Levine MN, J Hirsh, CS Landefeld, G Raskob: Haemorrhagic complications of an oral anticoagulant treatment. Chest 102:352-363, 1992.
14. Harenberg J, G Leber, CE Dempfle, DL Heene, R Zimmermann, W Kübler: Long term anticoagulation with low molecular weight heparin in outpatients with side effects on oral anticoagulation. Nouv Rev Fr Hematol 31:363-369, 1989.
15. Harenberg J, G Leber, R Zimmermann, W Schmidt: Thromboembolieprophylaxe mit niedermolekularem Heparin in der Schwangerschaft. Geburtshilfe Frauenheilkd 47:15-18, 1987.
16. Harenberg J, F Schwarz, R Dietz, G Leber, R Zimmermann, W Kübler: Antikoagulation mit niedermolekularem Heparin bei Patienten mit prothetischem Herzklappenersatz. Z Kardiol 76:284-288, 1987.
17. Chesebro JH, V Fuster, LR Elveback, DC McGoon, JR Pluth, FJ Puga, RB Wallace, GK Danielson, TA Orszulak, TM Piehler, HV Schaff: Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement. Danger of aspirin compared with dipyridamole. Am J Cardiol 51:1537-1541, 1983.
18. Lagerstedt CL, CG Olsson, BO Vagher, BW Oqvist, U Albretsson: Need for long term anticoagulant treatment in symptomatic calf vein thrombosis. Lancet 2:515-519, 1985.
19. Levine MN, G Raskoh, J Hirsh: Risk of haemorrhage associated with long term anticoagulant therapy. Drugs 30:444-460, 1985.
20. Nalbandian R, I Mader. JL Barrett, JF Rearce, EC Rupp: Petechiae, ecchymoses and necrosis of skin induced by coumarin congeners. JAMA 192:107-112, 1965.
21. Bell WR, RM Rovulli: Heparin-associated thrombocytopenia: A comparison of three heparin preparations. N Engl J Med 302: 902-907, 1980.
22. Griffith GC, G Nichols, JD Asher, B Flanagan: Heparin osteoporosis. JAMA 193:85-88, 1965.
23. Kakkar VV: Prevention of post-operative venous thromboembolism by a new low molecular weight heparin fraction. Nouv Rev Fr Hematol 26:277-282, 1984.
24. Kelton JG, J Hirsh: Bleeding associated with antithrombotic therapy. Semin Hematol 17:259-291, 1980.
25. Möllers M, W Kirschstein, U Staedt, DL Heene: White-clot-Syndrom nach neurochirurgischem Eingriff: Intensivemed Notfallmed 33:90, 1996. (Abstract).
26. Harenberg J, C Giese, CE Dempfle, G Stehle, DL Heene: Monitoring of heparin and low molecular weight heparin with capillary and venous whole blood. Thromb Huemostas 60:377-381, 1988.
27. Monreal M, E Lafoz, S Olive, L del Rio, C Vedia: Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. Thromb Haemostas 71:7-11, 1994.
28. Pini M, C Manotti, C Pattacini, R Quintavalla, T Poli, A Tagliaferri, AG Dettori: Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis. Thromb Haemostas 72:191-197, 1994.
29. Lee JH, PCY Liauw, ASH Ng: Low molecular weight heparin for thromboprophylaxis during pregnancy in 2 patients with mechanical mitral valve replacement. Thromb Haemostas 76:628-630, 1996.